Group 1 - Ripple Labs is leading an initiative to raise at least $1 billion to establish an XRP-focused cryptocurrency treasury [1][2] - The funds will be raised through a special purpose acquisition company, and Ripple Labs will also contribute some of its own XRP to the treasury [2] - This initiative follows similar moves by other companies, such as Trident Digital Tech Holdings planning to invest up to $500 million and Nature's Miracle Holding Inc. planning to invest up to $20 million for their own XRP treasury programs [3] Group 2 - The fundraising effort coincides with Ripple's $1 billion acquisition of GTreasury, a fintech firm specializing in treasury management solutions [4] - XRP is currently at the center of significant institutional interest, with 13 exchange-traded filings awaiting SEC review from major firms like WisdomTree, Grayscale, and Franklin Templeton, which have combined assets under management exceeding $1.6 trillion [5]

Investment & Funding - Some of Asia's largest Ethereum backers plan to launch a $1 billion ETH treasury firm [1]

Crypto firm Ripple said it has agreed to buy treasury management software provider GTreasury for $1 billion https://t.co/ty7QYD9WWJ ...

Ripple Acquires Treasury Management Firm for $1 Billion Amid DAT Boom► https://t.co/xDR6mL1XIJ https://t.co/xDR6mL1XIJ ...

RT Bitcoin For Corporations (@BitcoinForCorps)📺 The Bitcoin For Corporations Show Episode 17 now live — hosted by @BitcoinPierrePierre Rochard hosts @AlexandreLaizet of @_ALCPB to discuss the issuance of the first bitcoin-denominated convertible bonds, Europe's investing landscape, and why reflexive structural demand from treasury companies will be a key force in the next stage of the bitcoin market.00:00 – Intro: Demand Dynamics & Treasury Outperformance01:44 – Alexandre’s Bitcoin Journey05:20 – Corporate ...

Core Insights - The Ethereum Foundation plans to sell 1,000 ETH, valued at approximately $4.5 million, as ETH's price exceeds $4,500 for the first time since mid-September [1][2] - This sale is the Foundation's 17th ETH sale in 2025, leaving a remaining balance of about 222,720 ETH, worth around $1 billion at current prices [3] Group 1: Sale Strategy - The sale will utilize CowSwap's Time-Weighted Average Price (TWAP) feature to minimize market disruption and price volatility [1][2] - The proceeds from the sale will be converted into stablecoins to support ongoing operations, including ecosystem research, developer grants, and community donations [2][3] Group 2: Community Reactions - Frequent sales have raised concerns about creating bearish sentiment and weakening investor confidence, with some critics questioning the timing of sales during bullish market conditions [4] - Conversely, some community members appreciate the Foundation's transparency in publicly announcing its sales, which is seen as uncommon among large crypto organizations [5] Group 3: Alternative Suggestions - A crypto researcher proposed that the Foundation could leverage DeFi tools by supplying ETH on platforms like Aave to earn interest and borrow stablecoins, thus maintaining exposure to ETH's potential upside while accessing liquidity [4][5]

CRYPTO[.]COM PARTNERS WITH SOLS STRATEGIES TO EXPAND TREASURY OPERATIONS AND VALIDATOR INTEGRATION- @Cryptocom has entered into a strategic partnership with @SolStrategies_, a Canadian public company focused on investing in and building infrastructure for the Solana blockchain.- The collaboration will see Sols Strategies diversify its custody operations by using Crypto[.]com Custody, while also making its validator services available to institutional custody clients on the platform.Key Details:- Sols Strate ...

Partnerships & Integrations - CryptoCom teams up with SolStrategies to enhance treasury management and validator integration [1]

Core Viewpoint - Scilex Holding Company has signed a non-binding Memorandum of Understanding (MOU) with Biconomy.com to explore future cryptocurrency and treasury management strategies, potentially involving over a billion dollars in digital assets [1][2]. Company Overview - Scilex is focused on acquiring, developing, and commercializing non-opioid pain management products for acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases [4][6]. - The company targets high unmet needs and large market opportunities with non-opioid therapies, aiming to improve patient outcomes [4]. Product Portfolio - Scilex's commercial products include: - ZTlido® (lidocaine topical system) 1.8%, approved for neuropathic pain relief [4]. - ELYXYB®, an FDA-approved oral solution for acute migraine treatment [4]. - Gloperba®, the first liquid oral version of colchicine for gout flare prophylaxis [4]. - The company has three product candidates in development: - SP-102 (SEMDEXA), a viscous gel for lumbosacral radicular pain, with a completed Phase 3 study and Fast Track status from the FDA [5]. - SP-103, a next-generation lidocaine topical system for acute pain, recently completing a Phase 2 trial [5]. - SP-104, a low-dose naltrexone hydrochloride for fibromyalgia treatment [5]. Strategic Collaboration - The MOU with Biconomy aims to establish a cryptocurrency treasury management strategy that balances security, liquidity, compliance, and yield [2]. - The collaboration is intended to create long-term value in Scilex's digital assets and support the transition to a crypto-powered economy [3].

sharplink gaming deploying $3.6b eth treasury on linea. not staking for yield. buying infrastructure control through consortium ownership. gaming companies with real revenue don't pick chains for 5% apy, they pick chains they plan to dominate. linea at $2.7b fdv hasn't priced this. ...